SEC Tracker
Get the app
Person · CIK 1780081

Adrian R. Krainer

Director at Stoke Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$3.9M
Noticed on Form 144$3.7M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Stoke Therapeutics STOKCommon StockDirectly283,302Mar 10, 2026 · Filing · EDGAR
Stoke Therapeutics STOKDirector Stock Option (Right to Buy)
exercise $29.46, expires Jun 2, 2036, into Common Stock
Directly17,786Jun 3, 2026 · Filing · EDGAR

Sold and noticed by quarter

Adrian R. Krainer: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2025 to Q4 2026$2.3M$0Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $2.2M noticed on Form 144Q4 2025: $2.3M sold on Form 4Q1 2026: $1.5M noticed on Form 144Q1 2026: $1.6M sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q1 2025Q3 2025Q1 2026Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q1 2026$1.6M$1.5M
Q4 2025$2.3M$2.2M

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 15, 2025 · 3 notices
Mar 2, 202640,472 · ~$1.5MMar 2, 2026Sold as noticed Sold 40,472 in 2 sales, Mar 2 to Mar 10 · $1.6M Form 4 (1) · Form 4 (2)Filing · EDGAR
Nov 24, 202540,472 · ~$1.2MNov 24, 2025Sold as noticed Sold 40,472 at $29.72 on Nov 24 · $1.2M Form 4Filing · EDGAR
Nov 14, 202540,472 · ~$1.1MNov 14, 2025Sold as noticed Sold 40,472 in 2 sales, Nov 14 to Nov 14 · $1.1M Form 4Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Stoke Therapeutics STOK Director · filings 2019 to 2026 · sold $3.9M · $3.7M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Jun 3, 2026Grant or award from the company
Director Stock Option (Right to Buy)
+17,78617,786 directFiling · EDGAR
Mar 10, 2026Sale under a 10b5-1 plan−33,243$39.74$1.3M283,302 directFiling · EDGAR
Mar 2, 2026Sale under a 10b5-1 plan−7,229$39.66$287K316,545 directFiling · EDGAR
Nov 24, 2025Sale under a 10b5-1 plan−40,472$29.72$1.2M323,774 directFiling · EDGAR
Nov 14, 2025Sale under a 10b5-1 plan−19,790$26.61$527K384,928 directFiling · EDGAR
Nov 14, 2025Sale under a 10b5-1 plan−20,682$27.34$565K364,246 directFiling · EDGAR
Jun 3, 2025Grant or award from the company
Director Stock Option (Right to Buy)
+29,74729,747 directFiling · EDGAR
Jun 5, 2024Grant or award from the company
Director Stock Option (Right to Buy)
+7,6397,639 directFiling · EDGAR
Jun 13, 2023Grant or award from the company
Director Stock Option (Right to Buy)
+19,44119,441 directFiling · EDGAR
Jun 7, 2022Grant or award from the company
Director Stock Option (Right to Buy)
+21,00021,000 directFiling · EDGAR
Jun 8, 2021Grant or award from the company
Director Stock Option (Right to Buy)
+11,65011,650 directFiling · EDGAR
Jun 3, 2020Grant or award from the company
Director Stock Option (Right to Buy)
+14,77714,777 directFiling · EDGAR
Sep 10, 2019Grant or award from the company
Director Stock Option (Right to Buy)
+14,77714,777 directFiling · EDGAR
All 17 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Jun 5, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 12, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 4, 2026Form 4Stoke Therapeutics STOKFiling · EDGAR
Mar 2, 2026Form 144Stoke Therapeutics STOKFiling · EDGAR
Nov 26, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Nov 24, 2025Form 144Stoke Therapeutics STOKFiling · EDGAR
Nov 18, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Nov 14, 2025Form 144Stoke Therapeutics STOKFiling · EDGAR
Jun 4, 2025Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 7, 2024Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 15, 2023Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 8, 2022Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 25, 2021Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 5, 2020Form 4Stoke Therapeutics STOKFiling · EDGAR
Apr 15, 2020Form 3/AStoke Therapeutics STOKFiling · EDGAR
Sep 12, 2019Form 4Stoke Therapeutics STOKFiling · EDGAR
Jun 18, 2019Form 3Stoke Therapeutics STOKFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.